| inj | injection; injury, injured, injurious |
|---|---|
| HDMP | high-dose methylprednisolone |
| HIMP | high-dose intravenous methylprednisolone |
| IVMP | intravenous methylprednisolone |
| MP | macrophage; matrix protein; mean pressure; melphalan and prednisone; melting point; membrane potenti... |
| L | Lidocaine |
|---|---|
| LID | Lidocaine |
| xylocaine | Lidocaine |
| lidocaine | Lignocaine |
| LIDO | lidocaine |
oral (경구, 입의, 경구의, 구강, 구강의
| lidocaine | <cardiology, drug> A local anaesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of procaine but its duration of action is shorter than that of bupivacaine or prilocaine. Pharmacological action: anaesthetics, local, anti-arrhythmia agents. Decreases automaticity, depresses conduction in reentrant pathways and may raise fibrillation threshold, especially in combination with bretylium. Uses: The drug of first choice for ventricular arrhythmias, ventricular ectopy, and wide complex tachycardias of unknown origin. Dose: 1-1.5 mg/kg IV bolus, followed by additional 0.5-1.5 mg/kg every 5-10 min to a total of 3 mg/kg. Can be administered via the endotracheal tube. Use 2 to 2.5 times the intravenous dose. Upon return of circulation, use continuous infusion at 2 - 4 mg/min. Reduce the maintenance dose if decreased cardiac output or hepatic failure or more than 70 years of age. Potential complications: dizziness, drowsiness, disorientation, seizures, hypotension - causes vasodilation; myocardial depression at higher concentrations; heart block - only rarely seen with high levels. Chemical name: 2-(diethylamino)-N-(2,6-dimethylphenyl)-acetamide (15 Mar 2000) |
|---|---|
| lidocaine N-deethylase | <enzyme> Catalyzed mainly by cytochrome p-450 3a2 in rat liver microsomes Registry number: EC 1.- (26 Jun 1999) |
| methylprednisolone | <chemical> (6 alpha,11 beta)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,2-dione. A prednisolone derivative which has pharmacological actions similar to prednisolone. Pharmacological action: steroidal anti-inflammatory agents, antiemetics, glucocorticoids, synthetic, glucocorticoids, topical, neuroprotective agents. Chemical name: Pregna-1,4-diene-3,20-dione, 11,17,21-trihydroxy-6-methyl-, (6alpha,11beta)- (12 Dec 1998) |
| methylprednisolone acetate | 6-methylprednisolone 21 acetate;has the same actions and uses as methylprednisolone; aqueous suspensions are suitable for intrasynovial and soft tissue injection. (05 Mar 2000) |
| methylprednisolone hemisuccinate | <chemical> (6 alpha,11 beta)-21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-6-methylpregna-1,4-diene-3,20-dione. A water-soluble ester of methylprednisolone used for cardiac, allergic, and hypoxic emergencies. Pharmacological action: steroidal anti-inflammatory agents, antineoplastic agent, hormonal, glucocorticoids, synthetic, glucocorticoids, topical, neuroprotective agents. Chemical name: Pregna-1,4-diene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-6-methyl-, (6alpha,11beta)- (12 Dec 1998) |
| sodium methylprednisolone succinate | Sodium 6-methylprednisolone 21-succinate;it has the same metabolic and anti-inflammatory actions as the parent compound, methylprednisolone; because of its solubility it can be administered in small volumes. (05 Mar 2000) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|---|---|---|---|
|
동국염산리도카인초산메칠프레드니솔론주사 - 새창
|
동국제약 |
A00701421 | Lidocaine Hydrochloride, MethylPrednisolone acetate | 전문의약품 | 삭제 |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|